Markets
Sionna Therapeutics, Inc. (SION)
SIONNASDAQ-GMBiotechnology: Pharmaceutical Preparations
$3.74
+0.1700 (+4.76%) today
Closed, Nov 10, 4:00 PM ET
+4.76% 1D
- Market cap
- $167.29m
- P/E
- –
- EPS, last 4 quarters
- $-2.18
- Dividend yield
- –
- Day range
- –
- 52-week range
- $3.19 to $54.97
- Average volume
- 1.19m
- Previous close
- $3.57
Analysts
10 coveringHold0 buy, 10 hold, 0 sell
Targets a year out average $6.00, +60.4% from here
$5.00now $3.74$7.00
Earnings
next estimate $-0.6200Next report
Sep 2025
+11.5%
Dec 2025
+24.6%
Mar 2026
-15.4%
Jun 2026
-3.1%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$23.80m | -$23.61m | -$29.60m | -$32.47m |
| Net income | -$20.28m | -$20.44m | -$26.78m | -$29.89m |
News
8 latest- Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 YearsThe Motley Fool · 5 days ago
- Sionna Therapeutics, Inc. (SION) Loses 37.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks · Oct 12, 2026
- Is This Biotech Stock Too Cheap to Ignore After Its Latest Pullback?The Motley Fool · Sep 18, 2026
- Weekly Buzz: RARE, BAYRY Win Approvals; SION Cuts Jobs, GSK Deals; AZN, RHHBY Lead RTTNews · Sep 18, 2026
- SION to Cut Workforce by Nearly Half After CF Study Failure, Stock DownZacks · Sep 16, 2026
- Sionna Advances New CF Combo To Phase 2a After SION-719 Setback, Cuts Workforce 46%; Stock Down RTTNews · Sep 15, 2026
- Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?The Motley Fool · Sep 4, 2026
- Sionna Therapeutics Reaches Analyst Target PriceBNK Invest · Aug 25, 2026
The company
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that improve the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GM
- Region
- North America
- Website
- sionnatx.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.